Windtree Therapeutics, Inc.
WINT
$0.8522
$0.00330.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 200.65% | 77.14% | -217.66% | 298.27% | -16.47% |
| Total Depreciation and Amortization | -347.71% | -47.06% | 1,276.19% | 107.32% | -360.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -361.57% | -119.63% | 153.56% | -1,577.60% | 590.07% |
| Change in Net Operating Assets | 134.63% | -236.77% | 43.53% | 32.08% | 181.56% |
| Cash from Operations | 42.82% | -177.04% | 21.07% | 17.38% | 7.45% |
| Capital Expenditure | -- | 100.00% | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | 100.00% |
| Total Debt Issued | -100.00% | -87.97% | -- | -- | -- |
| Total Debt Repaid | 75.92% | -- | 100.00% | 0.43% | -0.43% |
| Issuance of Common Stock | -44.38% | -- | -100.00% | 81.06% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -21.49% | -- | -- | -- | -- |
| Total Dividends Paid | 10.66% | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 247.06% | 32.00% | -- | -- |
| Cash from Financing | -54.42% | 335.45% | 54.16% | 98.46% | 323.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -204.83% | 166.80% | 61.11% | 37.20% | 25.74% |